首页|IL-23在乳腺癌组织中的表达及其与患者临床病理特征的相关性

IL-23在乳腺癌组织中的表达及其与患者临床病理特征的相关性

扫码查看
目的 探讨白介素-23(Interleukin-23,IL-23)在乳腺癌组织中的表达及其与临床病理特征的相关性.方法 收集 2020 年 1 月—2020 年 12 月南充市中心医院确诊的 100 例乳腺癌患者的癌组织及癌旁组织,采用免疫组化法及Real-time PCR法测定两组组织中IL-23 蛋白及mRNA表达,比较乳腺癌组织与癌旁组织中IL-23 蛋白和mRNA表达水平并分析IL-23 表达与乳腺癌临床病理特征的关系.结果 IL-23蛋白主要在乳腺癌细胞的胞膜和胞浆中表达.乳腺癌组织中IL-23蛋白及mRNA的表达水平均高于癌旁组织(P<0.001),其表达与乳腺癌组织学分级、T分期、临床分期及Ki-67均呈正相关,与ER、PR表达均呈负相关(P<0.05),与乳腺癌神经脉管浸润、年龄、HER-2表达无关(P>0.05).结论 IL-23 可能参与乳腺癌的进展过程,其表达和ER、PR、Ki-67 等预后指标密切相关,提示其表达可能和预后有关,但还需进一步实验验证.
The expression of IL-23 in breast cancer tissues and its correlation with clinicopathological characteristics
Objective The aim of this study was to investigate the expression of IL-23(IL-23)in breast cancer and its cor-relation with clinicopathological characteristics.Methods The tumor tissues and adjacent tissues of 100 patients with breast cancer diagnosed in Nanchong Central Hospital from January 2020 to December 2020 were collected.Immunohistochemistry and Real-Time PCR were used to determine the expression of IL-23 protein and mRNA in the two groups of tissues.The expression of IL-23 protein and mRNA in breast cancer tissues and adjacent tissues were compared,and the relationship between IL-23 expression and the clini-copathological characteristics of breast cancer was analyzed.Results IL-23 protein was mainly expressed in the membrane and cyto-plasm of breast cancer cells.The expression of IL-23 protein and mRNA in breast cancer tissues were higher than those in adjacent tissues(P<0.001).The expression of IL-23 protein and mRNA was positively correlated with the histological grade,T grade,clinical stage and Ki-67 expression of breast cancer,negatively correlated with the expression of ER and PR(P<0.05),and was not related to neurovascular invasion,age and HER-2 expression in breast cancer(P>0.05).Conclusion IL-23 may participate in the progres-sion of breast cancer,and its expression is closely related to ER,PR,Ki-67 and other prognostic indicators,suggesting that its expres-sion may be related to the prognosis,but it needs further experimental verification.

Interleukin-23Estrogen receptorProgesterone receptorBreast cancerLymph node metastasis

杨闽叶、鲜童丞、刘景建、别俊、王杰、罗义

展开 >

川北医学院附属南充市中心医院乳甲血管外科(南充 637000)

川北医学院基础医学与法医学研究所

川北医学院附属南充市中心医院肿瘤科

白介素-23 雌激素受体 孕激素受体 乳腺癌 淋巴结转移

2024

实用肿瘤学杂志
黑龙江省,辽宁省,吉林省肿瘤防治办公室

实用肿瘤学杂志

CSTPCD
影响因子:0.528
ISSN:1002-3070
年,卷(期):2024.38(5)